OCS-01 in Treating Inflammation and Pain in Post-cataract Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

153

Participants

Timeline

Start Date

September 27, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions

Inflammation CornealPain, Postoperative

Interventions

DRUG

OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL

OCS-01 eye drops

DRUG

Placebo

Vehicle eye drops

Trial Locations (4)

Medical center, Houston

Medical center, San Antonio

Medical cennre, Petaluma

Medical center, Roseburg